Modesto Orozco’s lab (IRB Barcelona) has published a study on the reaction mechanism of DNAzymes in Nature Catalysis.
DNAzymes, which are catalysers formed by DNA, have applications in biomedicine and biotechnology. These research results will contribute to advances in the design and improvement of catalysers for therapeutic purposes.
Modesto Orozco’s laboratory (IRB Barcelona) has published a study on the source of asymmetry between nucleic acid hybrid (RNA and DNA) in CHEM (Cell Press).
The results are a promising step towards enhancing gene therapies, which are applicable to many diseases.
Kennedy’s disease is an untreatable neuromuscular disorder considered a rare disease
A study led by Xavier Salvatella may pave the way for new lines of treatment for Kennedy’s disease
A study done by scientists at IRB Barcelona can simulate and predict the shape of a molecule in function of its environment.
These results mark a milestone for the computational design of molecules with specific shape and features for agrochemical, technological and pharmaceutical applications.
The research group led by Travis Stracker identifies genes involved in male infertility in mice.
Their findings are relevant in humans and could explain undiagnosed cases of male infertility or subfertility.
In mice whose body clock—an internal mechanism located in the brain—does not work properly, each tissue still knows what time it is and has the capacity to respond to changes in light intensity.
The study, published in the journal Cell, is a collaboration between IRB Barcelona and the University of California, Irvine (US).
The new institution will represent and give visibility to young scientists, preferably from the field of experimental sciences
This research will help to identify those genes that play a key role in the initiation of metastasis
Metastasis causes 90% of cancer related deaths
Personal chronicle of the day by Tanya Yates
Although the event itself is not due to start till 10 am, at 7 am a small group of sleepy people from the Communications Department (including me) are already busy with the logistics of the event. Bit by bit, our eager “crazies” (different generations of our Crazy About Biomedicine programme for secondary school students) start to arrive, PhD students turn up to organise the multiple stands in the Science Fair, admin staff take up duties at the registration desk… it’s 10 am. I love punctuality!
People start to trickle down the street. It’s...
It is estimated that one in four people will require brain treatment at some point. While there are drug candidates for most diseases of the brain, the blood-brain barrier (BBB) poses an impassable obstacle for most of these compounds and a bottleneck for the delivery of drugs that could cure these patients.
In the Peptides and Proteins Lab at the Institute for Research in Biomedicine (IRB Barcelona), Dr. Meritxell Teixidó headsa line of research that, after 10 years, has led to the development of a technology called Gate2Brain. This patented technology consists of three...